New directions in toxicity testing

Annual Review of Public Health

Volumn 32, Issue , 2011, Pages 161-178

  Krewski, Daniel ^a   Westphal, Margit ^a   Al Zoughool, Mustafa ^a   Croteau, Maxine C ^a   Andersen, Melvin E ^b  

^a UNIVERSITY OF OTTAWA   (Canada)

^b HAMNER INSTITUTES FOR HEALTH SCIENCES   (United States)

Author keywords

computational toxicology; high throughput in vitro screens; pathway perturbations; regulatory risk assessment; toxicity pathways

Indexed keywords

ANDROGEN RECEPTOR; ANTIOXIDANT; BIOLOGICAL MARKER; ESTROGEN RECEPTOR; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR ALPHA; TOXIC SUBSTANCE; TRANSCRIPTION FACTOR NRF2;

ACT; ARTICLE; BIOINFORMATICS; BIOLOGY; CYTOTOXICITY; ENVIRONMENTAL EXPOSURE; FUNCTIONAL GENOMICS; GENETIC EPIDEMIOLOGY; HIGH THROUGHPUT SCREENING; HUMAN; MOLECULAR EPIDEMIOLOGY; NONHUMAN; OUTCOME ASSESSMENT; PHARMACOKINETICS; PRIORITY JOURNAL; RISK ASSESSMENT; STEM CELL; TOXICITY TESTING;

FORECASTING; HUMANS; NATIONAL ACADEMY OF SCIENCES (U.S.); TOXICITY TESTS; UNITED STATES;

EID: 79952851109     PISSN: 01637525     EISSN: None     Source Type: Book Series    
DOI: 10.1146/annurev-publhealth-031210-101153     Document Type: Article

References (109)

1. Akamatsu M, Fujikawa M, Nakao K, Shimizu R. 2009. In silico prediction of human oral absorption based on QSAR analyses of PAMPA permeability. Chem. Biodivers. 6:1845-66.
2. Alon U. 2007. Network motifs: theory and experimental approaches. Nat. Rev. Genet. 8:450-61. (Pubitemid 46789247)
3. Andersen ME, Al-Zhoughool M, Croteau M, Westphal M, Krewski D. 2010. The future of toxicity testing. J. Toxicol. Environ. Health. 13:163-96.
4. Andersen ME, Krewski D. 2009. Toxicity testing in the 21st century: bringing the vision to life. Toxicol. Sci. 107:324-30.
5. Andersen ME, Krewski D. 2010. The vision of Toxicity Testing in the 21st Century: moving from discussion to action. Toxicol. Sci. 117:17-24.
6. Andersen ME, Thomas RS, Gaido KW, Conolly RB. 2005. Dose-response modeling in reproductive toxicology in the systems biology era. Reprod. Toxicol. 19:327-37. (Pubitemid 40431228)
7. Arnot JA, Mackay D, Parkerton TF, Bonnell M. 2008. A database of fish biotransformation rates for organic chemicals. Environ. Toxicol. Chem. 27:2263-70.
8. Arnot JA, Meylan W, Tunkel J, Howard PH, Mackay D, et al. 2009. A quantitative structure-activity relationship for predicting metabolic biotransformation rates for organic chemicals in fish. Environ. Toxicol. Chem. 28:1168-77.
9. Au WW, Ruchirawat M. 2009. Biomarkers in population studies: environmental mutagenesis and risk for cancer. Rev. Environ. Health 24:117-27.
10. Basak SC, Mills D, HawkinsDM, Kraker JJ. 2009. Quantitative Structure-Activity Relationship (QSAR) modeling of human blood: air partitioning with proper statistical methods and validation. Chem. Biodivers. 6:487-502.
11. Blaauboer BJ. 2010. Biokinetic modeling and in vitro-in vivo extrapolations. J. Toxicol. Environ. Health. 13:242-52.
12. Blaauboer BJ, Farland W, Yenugadhati N, eds. 2010. Special Issue: The Future of Toxicity Testing. J. Toxicol. Environ. Health. 13:50-384.
13. Boekelheide K, Campion SN. 2010. Toxicity testing in the 21st century: using the new toxicity testing paradigm to create a taxonomy of adverse effects. Toxicol. Sci. 114:20-24.
14. Brazma A. 2009. Minimum Information About aMicroarray Experiment (MIAME)-successes, failures, challenges. Sci. World J. 9:420-23.
15. Bromberg KD,Ma'ayan A, Neves SR, Iyengar R. 2008. Design logic of a cannabinoid receptor signaling network that triggers neurite outgrowth. Science 320:903-9. (Pubitemid 351929582)
16. Bus JS, Becker RA. 2009. Toxicity testing in the 21st century: a view from the chemical industry. Toxicol. Sci. 112:297-302.
17. Cavallo D, Ursini CL, Rondinone B, Iavicoli S. 2009. Evaluation of a suitable DNA damage biomarker for human biomonitoring of exposed workers. Environ. Mol. Mutagen. 50:781-90.
18. Chapin RE, Stedman DB. 2009. Endless possibilities: stem cells and the vision for toxicology testing in the 21st century. Toxicol. Sci. 112:17-22.
19. CIRM workshop report. 2008. Stem cells in predictive toxicology. http://www.cirm.ca.gov/pub/pdf/ CIRM-Predictive-Tox.pdf.
20. Cochrane GR,Galperin MY. 2010. The 2010 Nucleic Acids ResearchDatabase issue and online database collection: a community of data resources. Nucleic Acids Res. 38:D1-4.
21. Cohen KM, Crofton K, Hartung T, Krewski D, Locke P, Stephens ML. 2008. Toxicity testing in the 21st century: better results, less use of animals. Environ. Forum 25:46-51.
22. Collins FS, Gray GM, Bucher JR. 2008. Toxicology. Transforming environmental health protection. Science 319:906-7. (Pubitemid 351263750)
23. Conolly RB. 2009. Commentary on "Toxicity Testing in the 21st Century: Implications for Human Health Risk Assessment" by Krewski et al. Risk Anal. 29:480-81.
24. Dearden JC, Cronin MTD, Kaiser KLE. 2009. How not to develop a quantitative structure-activity or structure-property relationship (QSAR/QSPR). SAR QSAR Environ. Res. 20:241-66.
25. Dellarco V, Henry T, Sayre P, Seed J, Bradbury S. 2010. Meeting the common needs of a more effective and efficient testing and assessment paradigm for chemical risk management. J. Toxicol. Environ. Health. 13:347-60.
26. Elliott ED. 2009. Needed: a strategy for implementing the vision. Risk Anal. 29:482.
27. Environ. Law Inst. 2008. Implementing alternatives to animal testing under U.S. toxics and pesticide laws. An Environmental Law Institute white paper. http://www.eli.org/pdf/research/ELI- Implementing-Alternatives-White- Paper-v.1-pdf.
28. Eur. Comm. 2009. Alternative Testing Strategies Progress Report. Replacing, Reducing, and Refining Use of Animals in Research. Brussels, Belgium: Eur. Comm.
29. Eur. Comm. 2010. European Center for the Validation of Alternative Methods (ECVAM). http://ecvam. jrc.ec.europa.eu/.
30. Gatzidou ET, Zira AN, Theocharis SE. 2007. Toxicogenomics: a pivotal piece in the puzzle of toxicological research. J. Appl. Toxicol. 27:302-9. (Pubitemid 47066756)
31. Ge F, He QY. 2009. Genomic and proteomic approaches for predicting toxicity and adverse drug reactions. Expert Opin. Drug Metab. Toxicol. 5:29-37.
32. Greenberg M, Lowrie K. 2009. From the editors. Risk Anal. 29:1645-6.
33. Harrill AH, Rusyn I. 2008. Systems biology and functional genomics approaches for the identification of cellular responses to drug toxicity. Expert Opin. Drug Metab. Toxicol. 4:1379-89.
34. Hartung T. 2009. A toxicology for the 21st century-mapping the road ahead. Toxicol. Sci. 109:18-23.
35. Hartung T. 2010. Lessons learned from alternative methods and their validation for a new toxicology in the 21st century. J. Toxicol. Environ. Health. 13:277-90.
36. HattisD. 2009. High-throughput testing-TheNRCvision, the challenge ofmodeling dynamic changes in biological systems, and the reality of low-throughput environmental health decisionmaking. Risk Anal. 29:483-84.
37. He M, Stoevesandt O. 2010. In situ biosynthesis of peptide arrays. Methods Mol. Biol. 615:345-56.
38. Heneweer M, Houtman R, Poortman J, Groot M, Maliepaard C, Peijnenburg A. 2007. Estrogenic effects in the immature rat uterus after dietary exposure to ethinylestradiol and zearalenone using a systems biology approach. Toxicol. Sci. 99:303-14. (Pubitemid 47250387)
39. HolsappleMP, AfshariCA, Lehman-McKeeman LD. 2009. Forum series: the "vision" for toxicity testing in the 21st century: promises and conundrums. Toxicol. Sci. 107:307-8.
40. Hood L, Galas D. 2003. The digital code of DNA. Nature 421:444-48. (Pubitemid 36157953)
41. Houck KA, Kavlock RJ. 2008. Understanding mechanisms of toxicity: insights from drug discovery research. Toxicol. Appl. Pharmacol. 227:163-78. (Pubitemid 351233054)
42. Huang Z, Li J, Zhang S, Zhang X. 2009. Inorganic arsenic modulates the expression of selenoproteins in mouse embryonic stem cell. Toxicol. Lett. 187:69-76.
43. Hubal EA. 2009. Biologically relevant exposure science for 21st century toxicity testing. Toxicol. Sci. 111:226-32.
44. Hubal EA, Richard A, Aylward L, Edwards S, Gallagher J, et al. 2010. Advancing exposure characterization for chemical evaluation and risk assessment. J. Toxicol. Environ. Health. 13:299-313.
45. Inglese J, Auld DS, Jadhav A, Johnson RL, Simeonov A, et al. 2006. Quantitative high-throughput screening: a titration-based approach that efficiently identifies biological activities in large chemical libraries. Proc. Natl. Acad. Sci. USA 103:11473-78. (Pubitemid 44182476)
46. Inglese J, Shamu CE,Guy RK. 2007. Reporting data from high-throughput screening of small-molecule libraries. Nat. Chem. Biol. 3:438-41. (Pubitemid 47080377)
47. Judson RS. 2010. Public databases supporting computational toxicology. J. Toxicol. Environ. Health. 13:218-31.
48. Judson RS, Houck KA, Kavlock RJ, Knudsen TB, Martin MT, et al. 2010. In vitro screening of environmental chemicals for targeted testing prioritization: the ToxCast project. Environ. Health Perspect. 118:485-92.
49. Karapetian RN, Evstafieva AG, Abaeva IS, Chichkova NV, FilonovGS, et al. 2005. Nuclear oncoprotein prothymosin alpha is a partner of Keap1: implications for expression of oxidative stress-protecting genes. Mol. Cell. Biol. 25:1089-99. (Pubitemid 40165815)
50. Kavlock RJ, Austin CP, Tice RR. 2009. Toxicity testing in the 21st century: implications for human health risk assessment. Risk Anal. 29:485-87.
51. Kavlock RJ, Dix DJ. 2010. Computational toxicology as implemented by the US EPA: providing high throughput decision support tools for screening and assessing chemical exposure, hazard and risk. J. Toxicol. Environ. Health. 13:197-217.
52. Kim HD, Shay T, O'Shea EK, Regev A. 2009. Transcriptional regulatory circuits: predicting numbers from alphabets. Science 325:429-32.
53. Kobayashi A, Kang MI, Okawa H, Ohtsuji M, Zenke Y, et al. 2004. Oxidative stress sensor Keap1 functions as an adaptor for Cul3-based E3 ligase to regulate proteasomal degradation of Nrf2. Mol. Cell Biol. 24:7130-39. (Pubitemid 39014439)
54. Kobayashi M, Li L, Iwamoto N, Nakajima-Takagi Y, Kaneko H, et al. 2009. The antioxidant defense system Keap1-Nrf2 comprises a multiple sensing mechanism for responding to a wide range of chemical compounds. Mol. Cell. Biol. 29:493-502.
55. Krewski D, Andersen ME, Mantus E, Zeise L. 2009. Toxicity testing in the 21st century: implications for human health risk assessment. Risk Anal. 29:474-79.
56. Krewski D, Hogan V, Turner M, Zeman P, McDowell I, et al. 2007. An integrated framework for risk management and population health. Hum. Ecol. Risk Assess. 13:1288-312. (Pubitemid 350125748)
57. Kwak MK, Wakabayashi N, Itoh K, Motohashi H, Yamamoto M, Kensler TW. 2003. Modulation of gene expression by cancer chemopreventive dithiolethiones through the Keap1-Nrf2 pathway. Identifi- cation of novel gene clusters for cell survival. J. Biol. Chem. 278:8135-45. (Pubitemid 36800555)
58. Li J, Johnson D, Calkins M, Wright L, Svendsen C, Johnson J. 2005. Stabilization of Nrf2 by tBHQ confers protection against oxidative stress-induced cell death in human neural stem cells. Toxicol. Sci. 83:313-28. (Pubitemid 40227901)
59. Locke P, MyersDB. 2010. Implementing the National Academy's vision and strategy for toxicity testing: opportunities and challenges under the US Toxic Substances Control Act. J. Toxicol. Environ. Health. 13:376-84.
60. MacDonald JS, Robertson RT. 2009. Toxicity testing in the 21st century: a view from the pharmaceutical industry. Toxicol. Sci. 110:40-46.
61. Manini P, De Palma G, Andreoli R, Marczynski B, Hanova M, et al. 2009. Biomarkers of nucleic acid oxidation, polymorphism in, and expression of, hOGG1 gene in styrene-exposed workers. Toxicol. Lett. 190:41-47.
62. Marinelli F, Pietrucci F, Laio A, Piana S. 2009. A kinetic model of trp-cage folding from multiple biased molecular dynamics simulations. PLoS Comput. Biol. 5:e1000452.
63. Mazzoleni G, Di Lorenzo D, Steimberg N. 2009. Modelling tissues in 3D: the next future of pharmacotoxicology and food research? Genes Nutr. 4:13-22.
64. Meek B, Doull J. 2009. Pragmatic challenges for the vision of toxicity testing in the 21st century in a regulatory context: another Ames test?. . .or a new edition of "the Red Book"? Toxicol. Sci. 108:19-21.
65. Merrick BA, Witzmann FA. 2009. The role of toxicoproteomics in assessing organ specific toxicity. EXS 99:367-400.
66. Motohashi H, Yamamoto M. 2004. Nrf2-Keap1 defines a physiologically important stress response mechanism. Trends Mol. Med. 10:549-57. (Pubitemid 39433824)
67. NakaoK, FujikawaM, Shimizu R, Akamatsu M. 2009. QSAR application for the prediction of compound permeability with in silico descriptors in practical use. J. Comput. Aided Mol. Des. 23:309-19.
68. Natl. Acad. Sci. 2010. Exposure science in the 21st century. http://dels-old.nas.edu/best/risk-analysis/ ExposureBackground.shtml.
69. Natl. Acad. Sci.,Natl. Acad. Eng., Inst.Med., Natl. Res. Counc. (NRC). 2010. Human and environmental exposure science in the 21st century. http://dels.nas.edu/Study-In-Progress/Human-Environmental- Exposure-Science/ DELS-BEST-09-02.
70. Natl. Res. Counc. (NRC). 1983. Risk Assessment in the Federal Government: Managing the Process. Washington, DC: Natl. Acad. Press.
71. Natl. Res. Counc. (NRC). 1996. Science and Judgment in Risk Assessment: Student Edition. Washington, DC: Natl. Acad. Press.
72. Natl. Res. Counc. (NRC). 2007. Applications of Toxicogenomic Technologies to Predictive Toxicology and Risk Assessment.Washington, DC: Natl. Acad. Press.
73. Natl. Res. Counc. (NRC). 2007. Toxicity Testing in the 21st Century: A Vision and a Strategy.Washington, DC: Natl. Acad. Press.
74. Natl. Res. Counc. Natl. Acad. (NRC). 2006. Toxicity Testing for Assessment of Enviornmental Agents. Washington, DC: Natl. Acad. Press.
75. Natl. Toxicol. Progr. 2010. Interagency Coordinating Committee on the Validation of Alternative Methods (ICCVAM). http://iccvam.niehs.nih.gov/.
76. Nirmalanandhan VS, Sittampalam GS. 2009. Stem cells in drug discovery, tissue engineering, and regenerative medicine: emerging opportunities and challenges. J. Biomol. Screen. 14:755-68.
77. Pampaloni F, Stelzer EH, Masotti A. 2009. Three-dimensional tissue models for drug discovery and toxicology. Recent Pat. Biotechnol. 3:103-17.
78. Pisabarro AG, Perez G, Lavin JL, Ramirez L. 2008. Genetic networks for the functional study of genomes. Brief. Funct. Genomic. Proteomic. 7:249-63.
79. Reddy B, Yang RSH, Clewell HJ, Andersen ME. 2008. Physiologically Based Pharmacokinetics: Science and Applications. Hoboken, NJ: Wiley.
80. Rhomberg LR. 2009. Risk assessment in the 21st century: changes wrought by changing science. Risk Anal. 29:488-89.
81. Rhomberg LR. 2010. Toxicity testing in the 21st century: How will it affect risk assessment? J. Toxicol. Environ. Health. 13:361-75.
82. Richard AM, Yang C, Judson RS. 2008. Toxicity data informatics: supporting a new paradigm for toxicity prediction. Toxicol. Mech. Methods 18:103-18. (Pubitemid 351419128)
83. Rotroff DM, Beam AL, Dix DJ, Farmer A, Freeman KM, et al. 2010. Xenobiotic metabolizing enzyme and transporter gene expression in primary cultures of human hepatocytes modulated by ToxCast chemicals. J. Toxicol. Environ. Health. 13:329-46.
84. Sauer H,Wartenberg M. 2005. Reactive oxygen species as signaling molecules in cardiovascular differentiation of embryonic stem cells and tumor-induced angiogenesis. Antioxid. Redox. Signal. 7:1423-34. (Pubitemid 41767977)
85. SchoetersG. 2010. TheREACHperspective towards a new concept of toxicity testing. J. Toxicol. Environ. Health. 13:232-41.
86. Seidle T, Stephens ML. 2009. Bringing toxicology into the 21st century: a global call to action. Toxicol. In Vitro 23:1576-79.
87. Shah I,Wambaugh J. 2010. Virtual tissues in toxicology. J. Toxicol. Environ. Health. 13:314-28.
88. Simmons SO. 2009. Hypoxia response: a model toxicity pathway for high-throughput screening. Toxicol. Sci. 112:1-3.
89. Stephens ML. 2010. An animal protection perspective on 21st century toxicology. J. Toxicol. Environ. Health. 13:291-98.
90. Stokstad E. 2009. Putting chemicals on a path to better risk assessment. Science 325:694-95.
91. Takahashi K, Tanabe K, Ohnuki M, Narita M, Ichisaka T, et al. 2007. Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell 131:861-72. (Pubitemid 350138099)
92. Takahata Y, Takarada T, Iemata M, Yamamoto T, Nakamura Y, et al. 2009. Functional expression of beta2 adrenergic receptors responsible for protection against oxidative stress through promotion of glutathione synthesis after Nrf2 upregulation in undifferentiated mesenchymal C3H10T1/2 stem cells. J. Cell Physiol. 218:268-75.
93. Talaska G, Al-Zoughool M. 2003. Aromatic amines and biomarkers of human exposure. J. Environ. Sci. Health Part C-Environ. Carcinog. Ecotoxicol. Rev. 21:133-64. (Pubitemid 37466163)
94. Taylor CF, Paton NW, Lilley KS, Binz PA, Julian RK Jr, et al. 2007. The minimum information about a proteomics experiment (MIAPE). Nat. Biotechnol. 25:887-93. (Pubitemid 47236919)
95. Taylor RC, Acquaah-Mensah G, Singhal M, Malhotra D, Biswal S. 2008. Network inference algorithms elucidate Nrf2 regulation of mouse lung oxidative stress. PLoS. Comput. Biol. 4:e1000166.
96. Tsuji JS, Garry MR. 2009. Advances in toxicity testing herald improvements and challenges for risk assessment. Risk Anal. 29:490-91.
97. U.S. Environ. Prot. Agency (EPA). 2009. The U.S. Environmental Protection Agency's strategic plan for evaluating the toxicity of chemicals. http://www.epa.gov/spc/toxicitytesting/.
98. U. S. Natl. Libr. Med. 2010. TOXNET: Toxicology Data Network. http://toxnet.nlm.nih.gov/.
99. Valavanidis A, Vlachogianni T, Fiotakis C. 2009. 8-hydroxy-2- deoxyguanosine (8-OHdG): a critical biomarker of oxidative stress and carcinogenesis. J. Environ. Sci. Health Part C-Environ. Carcinog. Ecotoxicol. Rev. 27:120-39.
100. Valerio LG Jr. 2009. In silico toxicology for the pharmaceutical sciences. Toxicol. Appl. Pharmacol. 241:356-70.
101. Walker NJ, Bucher JR. 2009. A 21st century paradigm for evaluating the health hazards of nanoscale materials? Toxicol. Sci. 110:251-54.
102. Wetmore BA, Merrick BA. 2004. Toxicoproteomics: proteomics applied to toxicology and pathology. Toxicol. Pathol. 32:619-42. (Pubitemid 39491933)
103. Xia M, Huang R, Witt KL, Southall N, Fostel J, et al. 2008. Compound cytotoxicity profiling using quantitative high-throughput screening. Environ. Health Perspect. 116:284-91. (Pubitemid 351395593)
104. Yang C, Hasselgren CH, Boyer S, Arvidson K, Aveston S, et al. 2008. Understanding genetic toxicity through data mining: the process of building knowledge by integratingmultiple genetic toxicity databases. Toxicol. Mech. Methods 18:277-95. (Pubitemid 351414968)
105. Yang F, Mei Y, Langer R, Anderson DG. 2009. High throughput optimization of stem cell microenvironments. Comb. Chem. High Throughput. Screen. 12:554-61.
106. Yu J, Vodyanik MA, Smuga-Otto K, Antosiewicz-Bourget J, Frane JL, et al. 2007. Induced pluripotent stem cell lines derived from human somatic cells. Science 318:1917-20.
107. Zhang Q, Battacharya S, Andersen ME, Conolly RB. 2010. Computational systems biology and doseresponse modeling in relation to new directions in toxicity testing. J. Toxicol. Environ. Health. 13:253-76.
108. Zhang Q, Pi J, Woods CG, Andersen ME. 2010. A systems biology perspective on Nrf2-mediated antioxidant response. Toxicol. Appl. Pharmacol. 244:84-97.
109. Zorina Y, Iyengar R, Bromberg KD. 2010. Cannabinoid 1 receptor and interleukin-6 receptor together induce integration of protein kinase and transcription factor signaling to trigger neurite outgrowth. J. Biol. Chem. 285:1358-70